Fidelity Investments’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $616K | Buy |
175,868
+12,186
| +7% | +$46.2K | ﹤0.01% | 3202 |
|
|
2026
Q1 | $632K | Buy |
163,682
+21,945
| +15% | +$86.4K | ﹤0.01% | 3032 |
|
|
2025
Q4 | $557K | Buy |
141,737
+23,032
| +19% | +$102K | ﹤0.01% | 3048 |
|
|
2025
Q3 | $554K | Buy |
118,705
+4,543
| +4% | +$16.4K | ﹤0.01% | 2996 |
|
|
2025
Q2 | $355K | Buy |
114,162
+17,366
| +18% | +$56K | ﹤0.01% | 3102 |
|
|
2025
Q1 | $327K | Sell |
96,796
-3,381
| -3% | -$15.8K | ﹤0.01% | 3054 |
|
|
2024
Q4 | $568K | Buy |
100,177
+7,679
| +8% | +$49.5K | ﹤0.01% | 2874 |
|
|
2024
Q3 | $541K | Buy |
92,498
+19,622
| +27% | +$143K | ﹤0.01% | 2820 |
|
|
2024
Q2 | $576K | Buy |
72,876
+6,259
| +9% | +$52.5K | ﹤0.01% | 2684 |
|
|
2024
Q1 | $620K | Sell |
66,617
-22
| -0% | -$186 | ﹤0.01% | 2655 |
|
|
2023
Q4 | $562K | Sell |
66,639
-7,641
| -10% | -$55.4K | ﹤0.01% | 2650 |
|
|
2023
Q3 | $576K | Buy |
74,280
+3,660
| +5% | +$33.4K | ﹤0.01% | 2592 |
|
|
2023
Q2 | $809K | Buy |
70,620
+696
| +1% | +$7.2K | ﹤0.01% | 2528 |
|
|
2023
Q1 | $539K | Buy |
69,924
+11
| +0% | +$87 | ﹤0.01% | 2669 |
|
|
2022
Q4 | $426K | Buy |
69,913
+11
| +0% | +$63 | ﹤0.01% | 2765 |
|
|
2022
Q3 | $414K | Sell |
69,902
-100
| -0.1% | -$640 | ﹤0.01% | 2838 |
|
|
2022
Q2 | $414K | Sell |
70,002
-16,425
| -19% | -$111K | ﹤0.01% | 2905 |
|
|
2022
Q1 | $659K | Buy |
+86,427
| New | +$386K | ﹤0.01% | 2904 |
|
|
2021
Q4 | – | Sell |
-1,169
| Closed | -$3K | – | 4984 |
|
|
2021
Q3 | $3K | Buy |
1,169
+238
| +26% | +$773 | ﹤0.01% | 3938 |
|
|
2021
Q2 | $4K | Buy |
931
+431
| +86% | +$1.95K | ﹤0.01% | 3802 |
|
|
2021
Q1 | $2K | Sell |
500
-47,929
| -99% | -$327K | ﹤0.01% | 3759 |
|
|
2020
Q4 | $346K | Sell |
48,429
-12,200
| -20% | -$117K | ﹤0.01% | 2711 |
|
|
2020
Q3 | $647K | Sell |
60,629
-169,100
| -74% | -$1.98M | ﹤0.01% | 2492 |
|
|
2020
Q2 | $2.9M | Hold |
229,729
| – | – | ﹤0.01% | 2195 |
|
|
2020
Q1 | $2.1M | Hold |
229,729
| – | – | ﹤0.01% | 2184 |
|
|
2019
Q4 | $3.21M | Sell |
229,729
-163,400
| -42% | -$2.38M | ﹤0.01% | 2151 |
|
|
2019
Q3 | $6.77M | Sell |
393,129
-139,000
| -26% | -$2.92M | ﹤0.01% | 1958 |
|
|
2019
Q2 | $14.5M | Sell |
532,129
-205,433
| -28% | -$4.7M | ﹤0.01% | 1751 |
|
|
2019
Q1 | $14.1M | Sell |
737,562
-173,500
| -19% | -$2.26M | ﹤0.01% | 1739 |
|
|
2018
Q4 | $8.56M | Sell |
911,062
-468,700
| -34% | -$6.01M | ﹤0.01% | 1853 |
|
|
2018
Q3 | $26.1M | Sell |
1,379,762
-952,459
| -41% | -$18.3M | ﹤0.01% | 1573 |
|
|
2018
Q2 | $45.6M | Sell |
2,332,221
-541,771
| -19% | -$10.7M | 0.01% | 1324 |
|
|
2018
Q1 | $54M | Sell |
2,873,992
-413,059
| -13% | -$8.93M | 0.01% | 1263 |
|
|
2017
Q4 | $54.6M | Sell |
3,287,051
-411,000
| -11% | -$7.05M | 0.01% | 1252 |
|
|
2017
Q3 | $76.1M | Sell |
3,698,051
-64,000
| -2% | -$722K | 0.01% | 1102 |
|
|
2017
Q2 | $33.7M | Hold |
3,762,051
| – | – | ﹤0.01% | 1467 |
|
|
2017
Q1 | $49.8M | Sell |
3,762,051
-211,800
| -5% | -$2.57M | 0.01% | 1299 |
|
|
2016
Q4 | $50.6M | Hold |
3,973,851
| – | – | 0.01% | 1285 |
|
|
2016
Q3 | $47.7M | Hold |
3,973,851
| – | – | 0.01% | 1315 |
|
|
2016
Q2 | $43.7M | Buy |
3,973,851
+71,503
| +2% | +$875K | 0.01% | 1333 |
|
|
2016
Q1 | $34.1M | Hold |
3,902,348
| – | – | ﹤0.01% | 1411 |
|
|
2015
Q4 | $85.5M | Buy |
+3,902,348
| New | +$89.9M | 0.01% | 1029 |
|
Other funds holding VYGR
AC
VPC
OM
Fidelity Investments's VYGR Position: Q2 2026 in Review
Fidelity Investments increased its Voyager Therapeutics (VYGR) stake by 7.4% in Q2 2026, buying an estimated $46.2K and bringing the position to 175,868 shares worth $616K. The position accounts for ﹤0.01% of the portfolio, ranked #3202.
Fidelity Investments first reported a position in VYGR in Q4 2015 and has held it in 42 quarters since. The position peaked at $85.5M in Q4 2015. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.
- Fidelity Investments held 175,868 shares of Voyager Therapeutics worth $616K as of Q2 2026.
- Fidelity Investments bought 12,186 Voyager Therapeutics shares in Q2 2026, an estimated $46.2K.
- Voyager Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3202 holding.
- Fidelity Investments first reported a position in Voyager Therapeutics in Q4 2015 and has held it in 42 quarters since.
- Fidelity Investments's Voyager Therapeutics position peaked at $85.5M in Q4 2015.
- 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.